MedTrace Logo

The Effect of PROSE or Scleral Lenses on Mental Health

NCT07195721 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2026-01-05

No results posted yet for this study

Summary

The goal of this prospective clinical trial is to evaluate the effect that prosthetic replacement of the ocular surface ecosystem (PROSE, BostonSight, Needham MA) treatment may have on mental health, particularly affective mood disorders. Correlation between changes in mental health and ocular symptom improvement and/or visual function improvement will be evaluated.

Conditions

  • Depression - Major Depressive Disorder

Sponsors & Collaborators

  • Boston Sight

    lead OTHER

Principal Investigators

  • Daniel Brocks, MD · Boston Sight

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-11
Primary Completion
2029-10-31
Completion
2029-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07195721 on ClinicalTrials.gov